TRVI vs. KTOS

Last updated Jun 5, 2026

TRVI (Trevi Therapeutics, Inc.) and KTOS (Kratos Defense & Security Solutions, Inc.) are both stocks. TRVI operates in Biotechnology (Healthcare), while KTOS operates in Aerospace & Defense (Industrials). Over the past 5 years, TRVI returned 45.90%/yr vs 19.54%/yr for KTOS. At a 0.16 correlation, their price movements are largely independent.

Performance

TRVI vs. KTOS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Trevi Therapeutics, Inc. (TRVI) and Kratos Defense & Security Solutions, Inc. (KTOS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TRVI achieves a 11.26% return, which is significantly higher than KTOS's -16.48% return.

TRVI

• 1D: 3.57%
• 1M: -4.98%
• YTD: 11.26%
• 6M: 3.41%
• 1Y: 111.70%
• 3Y*: 86.14%
• 5Y*: 45.90%
• 10Y*: —

KTOS

• 1D: 8.51%
• 1M: 6.90%
• YTD: -16.48%
• 6M: -18.38%
• 1Y: 58.10%
• 3Y*: 67.01%
• 5Y*: 19.54%
• 10Y*: 31.28%

*Multi-year figures are annualized to reflect compound growth (CAGR)

TRVI vs. KTOS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
TRVI Trevi Therapeutics, Inc.	11.26%	203.88%	207.46%	-30.57%	146.74%	-67.68%	-35.47%	-52.47%
KTOS Kratos Defense & Security Solutions, Inc.	-16.48%	187.76%	30.01%	96.61%	-46.80%	-29.27%	52.30%	14.35%

Correlation

The correlation between TRVI and KTOS is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.04
Correlation (3Y) Calculated over the trailing 3-year period	0.14
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (All Time) Calculated using the full available price history since May 8, 2019	0.16

The correlation between TRVI and KTOS shifts across timeframes, from 0.04 (1 year) to 0.16 (all time), reflecting how their relationship changes across market environments.

Fundamentals

EPS TRVI : -$0.43 KTOS : $0.17
Total Revenue (TTM) TRVI : $0.00 KTOS : $1.42B
Gross Profit (TTM) TRVI : -$31.00K KTOS : $259.40M
EBITDA (TTM) TRVI : -$49.16M KTOS : $78.30M

Return for Risk

TRVI vs. KTOS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TRVI

TRVI Risk / Return Rank: 84
TRVI Sharpe Ratio Rank: 86
TRVI Sortino Ratio Rank: 82
TRVI Omega Ratio Rank: 81
TRVI Calmar Ratio Rank: 87
TRVI Martin Ratio Rank: 84

KTOS

KTOS Risk / Return Rank: 64
KTOS Sharpe Ratio Rank: 68
KTOS Sortino Ratio Rank: 66
KTOS Omega Ratio Rank: 63
KTOS Calmar Ratio Rank: 62
KTOS Martin Ratio Rank: 61

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TRVI vs. KTOS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Trevi Therapeutics, Inc. (TRVI) and Kratos Defense & Security Solutions, Inc. (KTOS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TRVI	KTOS	Difference
Sharpe ratio: Return per unit of total volatility	1.84	0.82	+1.02
Sortino ratio: Return per unit of downside risk	2.44	1.51	+0.93
Omega ratio: Gain probability vs. loss probability	1.31	1.18	+0.13
Calmar ratio: Return relative to maximum drawdown	3.81	0.97	+2.84
Martin ratio: Return relative to average drawdown	8.54	2.04	+6.50
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TRVI vs. KTOS - Sharpe Ratio Comparison

The current TRVI Sharpe Ratio is 1.84, which is higher than the KTOS Sharpe Ratio of 0.82. The chart below compares the historical Sharpe Ratios of TRVI and KTOS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	TRVI	KTOS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.84	0.82	+1.02
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.52	0.38	+0.15
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.62	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.08	-0.13	+0.22

Drawdowns

TRVI vs. KTOS - Drawdown Comparison

The maximum TRVI drawdown since its inception was -95.45%, roughly equal to the maximum KTOS drawdown of -99.81%. Use the drawdown chart below to compare losses from any high point for TRVI and KTOS.

Drawdown Indicators

	TRVI	KTOS	Difference
Max Drawdown Largest peak-to-trough decline	-95.45%	-99.81%	+4.36%
Max Drawdown (1Y) Largest decline over 1 year	-29.50%	-60.15%	+30.65%
Max Drawdown (3Y) Largest decline over 3 years	-61.96%	-60.15%	-1.81%
Max Drawdown (5Y) Largest decline over 5 years	-80.26%	-69.39%	-10.87%
Max Drawdown (10Y) Largest decline over 10 years	—	-72.74%	—
Current Drawdown Current decline from peak	-9.55%	-95.98%	+86.43%
Average Drawdown Average peak-to-trough decline	-61.62%	-95.94%	+34.32%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.13%	28.62%	-15.49%

Volatility

TRVI vs. KTOS - Volatility Comparison

The current volatility for Trevi Therapeutics, Inc. (TRVI) is 13.27%, while Kratos Defense & Security Solutions, Inc. (KTOS) has a volatility of 24.01%. This indicates that TRVI experiences smaller price fluctuations and is considered to be less risky than KTOS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TRVI	KTOS	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.27%	24.01%	-10.74%
Volatility (6M) Calculated over the trailing 6-month period	39.96%	56.37%	-16.41%
Volatility (1Y) Calculated over the trailing 1-year period	61.92%	71.40%	-9.48%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	88.24%	52.11%	+36.13%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	99.30%	50.71%	+48.59%

Dividends

TRVI vs. KTOS - Dividend Comparison

Neither TRVI nor KTOS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both TRVI and KTOS in my portfolio?

TRVI and KTOS have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TRVI or KTOS?

KTOS has higher volatility (24.01%) compared to TRVI (13.27%). In terms of maximum drawdown, TRVI dropped -95.45% vs KTOS's -99.81%.

Which has better risk-adjusted returns?

TRVI currently has the higher Sharpe Ratio (1.84 vs 0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.